Brand Manager Dr Amy Scott said: "Because pain is often very difficult for owners to spot, the website highlights some of the common signs that indicate their cat or dog is suffering.
"We have also included a range of additional measures that owners can take to improve the quality of life and maintain the joint health of their pet once Metacam has been prescribed. These include weight management, regular and gentle exercise and alternative therapies such as hydrotherapy or the use of joint supplements such as Seraquin."
The website highlights common painful conditions such as arthritis, as well as more acute scenarios such as post injury or surgery. It also describes the changes in behaviour owners should be aware of that could indicate their pet is in pain, for example reluctance to exercise, change in appetite, displays of aggression or depression.
Amy added: "The correct use of NSAIDs is also an important consideration for effective pain management. To help with this, the website contains a section on Metacam administration for owners, featuring a short video on accurate dosing and treatment."
The 2020 OV Conference will offer up to 25 hours of CPD with lectures, workshops and Q&A sessions from world-class speakers in streams covering small animals, farm animals and equines. There will also be exclusive offers from industry sponsors and online networking opportunities.
The OV Conference provides an opportunity for OVs to discuss current topics of interest and recent developments in their work. Themes this year will include notifiable diseases, biosecurity and disease control, and export certification.
In addition to the live lectures, delegates will be able to view recordings of all the sessions on-demand for three months following the conference. The CPD on offer counts towards OV revalidation qualifications with the event open to all vets, as well as animal health paraprofessionals, nurses and practice managers.
David Babington MRCVS, Business Development Director at Improve International, said: "Moving the OV Conference online has given us an opportunity to harness the technology we use regularly in all of our veterinary training to bring OVs an exceptional but affordable CPD experience.
"Our excellent speakers are looking forward to sharing the latest updates in all aspects of OV work with our delegates and to discussing the challenges ahead, particularly in the light of the COVID-19 pandemic and with the UK moving inexorably towards leaving the EU at the end of the year.
"We’re looking forward to meeting our delegates old and new online at the OV Conference in September.”
The full programme and tickets are now available from https://officialvet.com
The first 150 tickets will get an ‘Early Bird’ 25% discount from £160 to £120+ VAT using the code UK.OV.EARLYBIRD.
The campaign is being fronted this year by a number of social media influencers, appropriately including Cat the Vet, aka Cat Henstridge (pictured right), Louisa The Vet and Alex And Bump.
Ceva has produced a number of materials to help practices get involved, including social media posts and templates which are now available from Ceva Territory Managers, or from the veterinary social media platform, Vet Social.
The company will also be launching an educational video that helps people recognise that older cats, and those with concurrent diseases, may have high blood pressure but show little in the way of recognisable signs.
Suzanne Page, Veterinary Surgeon and Amodip Product Manager at Ceva, said: “This year, in recognition of how busy practices are, we wanted to give veterinary teams resources that provide a straightforward and simple way to raise feline hypertension awareness.
"Hypertension is so difficult for owners to notice, so we are working hard with influencers to spread the word.
"There will also be leaflets to share and a new website for cat owners at www.catbloodpressure.com.”
For those wanting to brush up on hypertension, there's Ceva's free CPD course, led by Dr Sarah Caney, Feline Medicine Specialist and CEO of Vet Professionals, available here.
Medivet Veterinary Partnership has announced the acquisition of a two-branch practice in Bedfordshire, Ridgeway Veterinary Centre, Flitwick, and Kempston Veterinary Clinic, Bedford, belonging to John Wakely, BVetMed MRCVS.
Current practice vets, John Wakely and Leo Weindrich, as well as all the nursing and reception staff, will remain at the practices. John said: "We are very pleased to be joining the Medivet Group. We will be able to offer our clients a wider range of services and expertise, as well as pass on price reductions for some services, which being part of a larger group enables us to do."
"On a practical level, our clients won't notice much difference. Our staff will remain the same and I will still be their main vet. On a professional level, because the day-to-day administration will be handled by the Medivet head office, I am looking forward to spending more time being a vet. It will give me the time to acquire more expertise in the areas I have always been interested in."
Medivet partner John Smithers said: "John Wakely's practices enjoy an excellent reputation. They will remain local veterinary practices, based, as they always have been, on the high standards of care and strong relationships the staff have developed with their patients and clients over many years. Becoming part of a group will give the practices access to additional skills, facilities and support of staff at other local branches."
This acquisition brings the total number of practices Medivet owns in Bedfordshire to four, the others situated in Biggleswade and Sandy, and brings the total number of practices in the Medivet group to 80.
The move comes as the whole agriculture industry, co-ordinated by agricultural and food industry alliance RUMA (which promotes responsible use of medicines in farming), looks to build on the recent 10% reduction in use of antibiotics to treat farm animals.
The BCVA’s Dr Elizabeth Berry, who prepared the recommendations, said that whilst the responsible use of antibiotics has been promoted for many years across farming sectors, there is still the potential to reduce use in some areas and to move away from products which are important for human health.
She said: "This is an official position from BCVA to our members but we would like to see all in the cattle sectors embrace these recommendations in the understanding that we need to play our part in increasing responsible use of antibiotics.
"Work still needs to be done to establish the levels currently being used in cattle so that appropriate targets can be set but there are measures that can immediately be adopted.
"So we are recommending reducing both the overall amount of antibiotics used in cattle practice and minimising the use of the high priority CIAs – namely third and fourth generation cephalosporins, fluoroquinolones and colistin. These drugs should only be used where they have been demonstrated by sensitivity testing to be the only suitable choice to avoid unnecessary suffering."
The BCVA, which has over 1,100 practising members covering around 85% of vets working with cattle, is also recommending that use of antibiotics as a preventative treatment is avoided wherever possible as long as animal welfare is not compromised.
Dr Berry added: "Where preventative treatment – or prophylaxis – is used it should be regarded as an interim measure whilst alternative management or vaccination strategies are implemented.
"For example, all cows which comply with recommendations for using an internal teat sealant should be considered for non-antibiotic treatments at drying off."
The BCVA continues to advise that every farm should have a herd health plan which embraces all of the disease control strategies appropriate for disease reduction on that farm. In addition, farm management best practice should be followed, such as the guidelines issued by Red Tractor farm assurance.
Dr Berry says BCVA further recommends that all herds should establish their BVD status and eradicate the disease where it is found. "BVD can have a detrimental effect on incidence of many diseases and its eradication will have a significant impact on the need for antimicrobial use.
"We also continue to recommend the use of diagnostics to identify disease so that appropriate treatments can be selected and vaccination programmes instituted to prevent or reduce the severity of disease."
BCVA’s confirmation of its official position has been welcomed by RUMA. Secretary General John FitzGerald says that while RUMA’s promotion of responsible use over the past 20 years means the UK remains among the lower users of antibiotics in farming in Europe1, more needs to be done.
"The BCVA’s position is clear and leaves no doubt that action needs to be taken,” says Mr FitzGerald. “It is underpinned by science, recognising that banning preventative use outright or access to critically important antibiotics is not an answer. Both are important tools in fighting disease and preventing suffering so we still need them – but we need to use them more strategically and only when no other options exist."
The complete list of guidelines can be downloaded from the BCVA website www.bcva.eu.
Members of the profession are of course more likely than most to receive information about violent incidents that constitute abuse against an animal, and research has shown that such cases are often the index case that trigger investigation into violent households.
Jennie Bartholomew, education coordinator at the BSAVA said: "Suspecting animal abuse can be an alarming and sensitive issue to confront but our training courses should give veterinary teams the skills and support they need to help deal with such cases."
The sessions will provide guidance on setting up a practice protocol and identifying a Safeguarding Liaison Officer (SLO) who will aid practice staff in suspected cases of abuse. Through the SLO, relationships with RSPCA officers, police domestic abuse officers and aid agencies can be set up to give staff expert support to call upon if they suspect animal or human abuse.
Freda Scott-Park is a BSAVA Past President and is one of the lecturers on the Links Veterinary Training Initiative courses. She said: "There are few veterinary practices that do not encounter animal abuse, not daily, but the incidence is increasing.
"Cases can be quite complicated to diagnose but often vets find they develop a sixth sense that something isn’t right. By defining the complexities and difficulties in diagnosis, the course aids vets, veterinary nurses and receptionists to understand how to proceed – to ask the right questions and how to seek help from the correct people.
"Information from the veterinary practices may allow human healthcare professionals to investigate troubled households, offering support to the family and potentially improving or saving a human victim’s life."
Three sessions have been organised around the country during 2019. They are free for BSAVA members, with a non-member price of £40.00.
Sunday 23 June: Wetherby Racecourse, Yorkshire
Monday 16 September: Woodrow House, Gloucester
Sunday 27 October: Jesus College, Cambridge
Norbrook has launched Loxicom 0.5mg/ml oral suspension for small dogs, indicated for the alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders.
Loxicom Oral Suspension comes in a clear 15ml bottle which allows vets and clients to monitor levels of the product and re-order when necessary.
Loxicom 0.5mg/ml for Dogs comes with two sizes of syringe, a 1ml syringe graduated from 0.25kg-5kg to treat even the smallest of dog breeds accurately, and a 5ml syringe graduated from 1kg-25kg to treat small and medium dog breeds. The syringes plug securely into the bottle to ensure a tight-fitting connection and minimal leakage when administering the product.
This new oral suspension joins the range of 1.5mg/ml oral suspensions for Dogs and 5mg/ml injections for Dogs and Cats, launched in 2009, and the 0.5mg/ml oral suspension for Cats launched earlier this year at the BSAVA Congress.
Protexin Veterinary has launched Cystophan, a new product to aid in the management of Feline Idiopathic Cystitis (FIC).
Protexin says nearly 50% of cats with FIC will have a recurrent signs within one year, so it is important to offer a high quality product to manage the condition correctly.
Cystophan combines 3 key ingredients in a tasty artificial chicken flavour capsule for optimum effectiveness:
Cystophan is available in tubs of 30 and 240 capsules.
For further information please visit www.protexin.com.
Ceva Animal Health has announced the addition of a new CPD module to its Cardio Academy, covering the clinical significance of heart murmurs in cats.
Hosted by Virginia Luis-Fuentes, Professor of Veterinary Cardiology at the Royal Veterinary College, the online seminar provides guidance in deciding which heart murmurs are significant and working out which are more likely to develop complications, such as congestive heart failure or aortic thromboembolism.
According to the company, up to 40% of cats will have heart murmur at some point in their life, but are often clinically normal at presentation. To make things more confusing, says Ceva, 50% of cats with congestive heart failure do not have a heart murmur at all.
The module lasts for 20 minutes and, after viewing, delegates receive a CPD certificate by answering questions relating to the session.
To access this module, and 20 hours of online cardiology CPD, visit www.cardioacademy.cevalearn.com.
Zoë Coker, a co-founder of VETbytes alongside Bronwen Eastwood, said: "This new feature will allow users to access real-time updates to the app so they can be assured they are following the most up-to-date clinical guidance."
The app, which was launched in partnership with the BSAVA earlier this year, covers more than 100 topics and includes other features such as drug (and CRI) calculators, a quick reference section and links to hundreds of source abstracts, as well as CPD accreditation for reflective learning.
It is available at a discount to BSAVA members and free to veterinary students.
BSAVA President Professor Ian Ramsey said: “The latest addition to the app advances our joint goal with VETbytes, to provide the latest practical, accessible, evidence-based resources for the small animal veterinary community.”
To view the ‘latest updates’ feed: https://vetbytes.co.uk/latest-updates.
For more information, visit: www.vetbytes.co.uk.
The research was carried out by the Kansas State University College of Veterinary Medicine Center for Outcomes Research and Epidemiology, Holland Management Services, Zoetis and the Pet Insight Project team at Kinship (part of Mars Petcare).
For the study, researchers recorded pet scratching activity use Whistle canine activity trackers. They then compared that information with the visual observations of 358 pet owners who graded the severity of their pet’s scratching activity on a scale from 0, which represents a normal dog (“itching is not a problem for my dog”) to 100, corresponding to extreme itching (“itching disrupts my dog’s sleep, eating, play and exercise”).
The researchers found that measurements of scratching severity determined by the Whistle activity tracker corresponded to the owner’s overall impression of the pet’s pruritus, or itch, level. As scratching severity increased, as measured by the Whistle device, owner’s assessment scores significantly increased as well (P < 0.01).
Aletha Carson DVM, Data and Clinical Studies Senior Manager for Kinship said: “Pet owners can overlook the subtle changes in behaviour that may be a warning sign for an underlying issue and are often too late to recognise their beloved companion is suffering.
“This new method of analysing pet behaviours provides pet owners with an ‘always-on’ monitor that may be helpful in keeping their dogs healthy and happy.
“It may also prove to be quite useful for veterinarians who need an objective way to gauge a pet’s response to prescribed therapies used to reduce inflammation and scratching without requiring time-intensive monitoring from the owner.”
Details of the research were shared at the European Veterinary Dermatology Congress on September 17, 2021.
The RCVS Disciplinary Committee has dismissed a case against an Essex-based veterinary surgeon, having found him not guilty of charges relating to the measurement of horses and ponies.
At the ten-day hearing, Marc Auerbach of Oak Equine Veterinary Surgery, Ongar, answered charges relating to measuring the height of 29 horses/ponies presented for measurement by two agents in early 2009. Dr Auerbach had undertaken these measurements as an Official Measurer (OM) for the Joint Measuring Board (JMB), which provides a system for independently measuring and certifying the size of competition horses/ponies. An animal's financial value relates to its size, with larger animals being more likely to win in their competitive class.
The case centred on the expected accuracy of such measurements, whether Dr Auerbach was dishonest in colluding with the agents, or whether there had been signs of malpractice which a reasonably competent vet acting as an OM ought to detect.
From evidence submitted, the Committee determined a margin for measurement accuracy, and consequently dismissed from its consideration ten animals where the difference between the initial measurement and the re-measurement was 3 cm or less. However, the College submitted that the average difference was so great that, either, Dr Auerbach had failed to take sufficient steps to ensure that the correct measurements were recorded, or else he had been dishonest. Dr Auerbach's Counsel accepted the inference that presenting agents were dishonest, but denied that Dr Auerbach was dishonest or had failed to pick up signs of malpractice on the part of the agents.
The Committee was of the view that there may be unscrupulous presenters capable of materially interfering with the height of horses. While it was unable to determine with certainty the extent to which it could be done, the Committee formed the view that unscrupulous interference (together with intrinsic variables) could have caused the differences between measurement and re-measurement in the 19 horses.
The Committee noted there was no evidence of improper payments being received by anyone. It also accepted evidence that Dr Auerbach was not a dishonest man, taking into account his record of 23 years of honesty and excellence in the profession, unchallenged character references and the lack of any credible motive for him to act dishonestly.
Next, the Committee considered whether there had been signs of preparation malpractice which ought to have been picked up by any reasonably competent veterinary surgeon acting as an OM. The College submitted that Dr Auerbach had failed to take several steps including the amount of time and attention given to the animals he measured, and whether they might be drugged or sedated.
The Committee concluded from the evidence, including scientific papers, that mildly sedated animals may not be distinguishable from properly prepared animals; well-behaved horses were not an indication that something was amiss. The Committee accepted that Dr Auerbach took around 15-20 minutes to measure each of the horses presented on 9 January; and, in the absence of guidance from the JMB, it could not conclude this was rushed or unreasonable. Consequently, the Committee was unable to be satisfied, so that it was sure, that the allegation of failure to take sufficient steps to ensure the recording of correct measurements was proved.
"Accordingly, the decision of the Committee is that the facts set out in the Charge in relation to all the horses and ponies listed have not been proved to the necessary standard of proof," said Prof Peter Lees, speaking on behalf of the Committee as he directed the charges be dismissed.
Elanco Animal Health has announced the launch of a Milbemax television advertising campaign to educate pet owners about the importance and ease of worming.
The 30-second advertisement will appear as pre-roll to video content on a number of websites from the end of August, and will broadcast on mainstream TV channels including ITV1, Channel 4, Channel Five, Sky, ITV2, ITV3, E4, More4, Film4, UKTV and Five Digital in mid-September to reach an estimated nine million people – of which nearly three million will be identified/targeted pet owners.
Elanco says the advert is designed to target female pet owners between the ages of 25 and 49 and drive them to seek further information and buy pet wormers from their local veterinary surgeon with the call to action: ‘Make an appointment with your vet to find out how easy worming your pet can be.’
Viewers watching the online advertisement will be able to click through to campaign specific pages on Elanco’s WormPatrol website - www.wormpatrol.co.uk/easyworming - where they can use 'Find a Vet', a worm risk checker and worming reminders to connect them with veterinary practices. The advertisement will also be available to view on the WormPatrol website.
The campaign is supported by a range of educational marketing materials and initiatives which are available to Milbemax customers from the vet section of the WormPatrol website or from their local Elanco companion animal territory manager.
The materials include a video to embed in practice websites and to use on social media, a subtitled version of the video for waiting rooms, a range of pet owner worm education materials, social media resources and SMS text message broadcasts.
Matthew Rowe, marketing manager at Elanco Animal Health, said: “Elanco is committed to encouraging responsible pet ownership; the new Milbemax advertising campaign will educate pet owners about the importance and ease of regular worming while driving them to veterinary practices for further information and to purchase pet wormers.”
For further information please contact your local Elanco Animal Health territory manager or email elancoCAH.uk@elanco.com.
Following the launch of Libromide, the only licensed formulation of potassium bromide in the UK for canine epilepsy, Genitrix has linked up with NationWide Veterinary Laboratories to offer a discounted blood test service to veterinary practices.
Genitrix says it is offering the discounted blood tests to help practices and encourage owners to test regularly, thus ensuring that the level of Libromide in dogs undergoing treatment remains within the recommended therapeutic range.
According to the company, factors which can cause the level to move out of therapeutic range include an increase in the chloride content of the diet or the administration of other drugs. Because Libromide takes a few weeks to reach a steady therapeutic state, testing at four, eight and twelve weeks is also recommended at the commencement of treatment to confirm that the rise to therapeutic level takes place.
To take advantage of the discount scheme, practices can download a test form from the Genitrix website (http://www.genitrix.co.uk/) or call its head office on 01403 786345. Copies are also available from wholesalers.
Rob Watkins, Marketing Director at Genitrix, said: "Regular blood testing of epileptic dogs is an essential element of a successful treatment regime and is recommended by all canine epilepsy specialists. Unfortunately, feedback from practices suggests that owners are sometimes reluctant to comply with this advice and that the cost of testing is frequently an issue.
"We've launched the scheme to help practices increase compliance by making it significantly cheaper. Taking advantage of this scheme for blood testing is also convenient for practices now that the test forms can be downloaded as well as ordered by phone.
"Recent data suggests that canine epilepsy affects four in every hundred dogs making it a common disease affecting dogs in the UK. Following on from the launch of Libromide, we hope that the discounted blood test scheme will be another step forward in the move to improve treatment approaches for this distressing disease."
Hill's Pet Nutrition is offering veterinary surgeons, vet students and nurses in the UK an opportunity to look round its Pet Nutrition Centre in Topeka, Kansas, via a live webcast to be delivered at 7pm on Tuesday 11th January 2011.
To join the webcast, which will last around 1.5 hours, go to http://www.fc-tv.com/webcast/keystone/hills/jan-11-11 and enter the password pnctour. This event is specifically for veterinary surgeons, veterinary students and veterinary nurses only.
Tim Dobbins, Associate Veterinary Affairs Manager said: "We look forward to our colleagues joining us for this special live webcast and hearing some of the latest thinking that explains the science behind some of our most exciting products."
Animal Health and Veterinary Laboratories Agency (AHVLA) has announced the formation of a new independent advisory group to recommend a future delivery model for veterinary surveillance in England and Wales.
The Advisory Group will be chaired by Dirk Pfeiffer, Professor of Veterinary Epidemiology at the Royal Veterinary College. According to the AHVLA, it will include representatives from government, the veterinary profession and the livestock farming and private laboratory industries and is being created so all those with an interest in veterinary surveillance can shape a future model and ensure that all issues are thoroughly considered.
Veterinary surveillance seeks to identify new or re-emerging threats to our livestock population and to public health. It involves a partnership approach between livestock keepers, private veterinary surgeons, the Scottish Agricultural College, industry bodies and AHVLA in order to effectively gather and assess intelligence.
AHVLA is seeking to identify ways to undertake veterinary surveillance both more effectively and at an affordable cost to the taxpayer. Work in this area has been on-going since 2010, and the merger of the former Animal Health and Veterinary Laboratories Agency (VLA) has created opportunities to review how veterinary surveillance can best be delivered.
The new model will aim to address capacity imbalances in the current service where provision sometimes outstrips demand. The independent advisory group are also expected to recommend how better and closer working methods across the partners can make the surveillance stronger as well as more cost effective.
Surveillance has historically been based on in-depth investigation of disease incidents with an emphasis on post mortem examinations carried out at AHVLA's regional laboratories. This system is a key element in the government's risk-based approach to the management of animal disease related threats.
AHVLA says that the current model, although successful in identifying diseases in the past, can be improved upon. A recent internal AHVLA report identified viable options for achieving better surveillance at the same or lower cost by, for example, exploring moving towards risk and intelligence based surveillance and improving the value added by working more closely in partnership with vets and their farmer clients and other sources of intelligence data.
In mid-January 2012, AHVLA will also be publishing, and publicising, an online survey aimed at individual veterinary practioners and livestock keepers. The survey will seek individual opinions on the inputs, mechanisms, outputs and value of surveillance in England and Wales Work is expected to run until spring 2012, following which recommendations on a way forward will be made.
Carl Padgett, President of the BVA, said: “Veterinary surveillance is an essential component in our animal health, public health, food security, and international trade work.
“The emergence of Schmallenberg virus in ruminants in northern Europe demonstrates the current value and ongoing need for a robust surveillance system to work both nationally and internationally.
“The BVA welcomes the establishment of the advisory group and particularly the wide range of veterinary expertise and experience that is represented on the group. It is important that views from both veterinary practitioners and veterinary scientists are fed into this review.
“While we understand that AHVLA and Defra must ensure value for money from the surveillance network, any future model must be shaped by good surveillance strategies, not the need to cut costs.
“We urge all practitioners in England and Wales to contribute to the discussions by completing the online survey.
“We look forward to engaging with the advisory group as it carries out the review and beyond.”
Lynda Maris, NexGard™ Spectra Product Manager said: "The campaign, which is designed to raise awareness of the rising threat from ticks, lungworm and other parasites that can endanger the health of pets and their owners, is reaching millions of pet owners."
A radio day, during which presenter Jenni Falconer and Merial vet Mike Woodhouse (pictured) discussed parasites and called on owners to visit their practice, apparently reached nearly 3 million listeners via 16 radio stations from BBC Radio Guernsey in the south, to Waves radio in Peterhead and Aberdeen.
The campaign has also been promoted with advertising on Newslink, which broadcasts to 287 stations including: Kiss, Capital, Star, Magic, Talk Sport, Classic and Absolute.
Participating practices have been send campaign support packs and Merial has provided educational and competition social media content to share on Facebook and Twitter. According to the company, its campaign Facebook page has reached reached over 1 million unique users in the last 28 days. Over the same period, Merial says 25,000 unique users have received campaign content on Twitter.
Practices can also direct clients to the campaign website www.petparasiteaction.co.uk.
Pet Parasite Action runs throughout June and July, so there's still time to get involved. For more information, contact your Merial Territory Manager, or call the company on 0870 6000 123.
The survey was held in mid-June and gathered 196 responses from UK practices. That compared with the 532 responses to the initial survey conducted early in April and 251 responses to the second survey conducted at the start of May.
One of the main findings was a marked increase in the number of practices running a near-normal caseload, from 3% in May to 32% in June. Practice turnover data similarly reflected a shift back towards normality, with 46% now reporting a reduction of less than 25%, compared with 19% last month.
Other findings included:
Lizzie Lockett, RCVS CEO, said: "This latest survey has demonstrated a continuation of the previous survey’s positive trends including an increase in practice turnover with more practices approaching a ‘near normal caseload’ and with a reduction in the number of practices impacted by staff self-isolating or with confirmed cases of Covid-19.
“In this survey we also asked about what difficulties practices may be experiencing with EMS placements for vet students and VN training placements as a result of Covid-19, and this will help us to understand how we can better support students and practices in these areas.
“We will continue to monitor the situation via these regular surveys, with the next one planned for later this summer. I would urge as many practices as possible to continue to complete them, so that we can build up a stronger evidence-base on how veterinary businesses have been affected and how they are recovering.
"This information is not only vital for our own policy decisions but also allows us to present a stronger case to the Government and other public bodies where we wish to influence the decisions they make that will impact the veterinary professions and businesses.”
The survey results can be read in full at www.rcvs.org.uk/coronavirus-resources.
The procedure involves introducing a catheter through the jugular, then using fluoroscopy and transoesophageal echocardiography to guide it from the right atrium through to the left side of the heart to relieve abnormal high pressures in the left atrium.
Willows says it is one of only a few centres across Europe equipped to carry out the procedure and that typically, patients who undergo TSP can be discharged from hospital the day after surgery.
Fabio Sarcinella (pictured right), an RCVS and European specialist in small animal cardiology at Willows, said: “Early clinical evaluation of the TSP procedure in humans over the last few years has shown improved quality of life and reduced clinical signs in patients with heart failure.
“The procedure has also been associated with low-risk and a meaningful drop in left atrial pressure of the affected patients.”
Fabio added: “As well as being minimally invasive, the improvement in heart chamber pressures via TSP often allows for a reduction in the dose of water tablets which are used to control the heart failure signs in the lungs.
"Lowering the dose reduces the risk of side effects related to these drugs such as kidney failure.”
Willows says TSP is most commonly used for left atrial decompression in dogs with heart failure and concurrent renal disease or that have advanced heart failure but continue to have symptoms despite optimal medical treatment.
www.willows.uk.net
Invicta Animal Health has launched a new identification service for ChroMyco Duo dermatophyte kits in partnership with Axiom Veterinary Laboratories.
Veterinary practices can now send positive ChroMyco plates to Axiom and receive a species identification report for the specially discounted price of £8.00.
Rob Watkins, Managing Director of Invicta Animal Health said: "We are delighted to launch this service in response to customer feedback. This enables practices to gain a positive dermatophyte diagnosis in as little as three to six days so that treatment can be commenced promptly. Then, by sending the plate to Axiom, the actual species can be subsequently identified.
Axiom, with its innovative microbiology department and dedication to quality combined with its reliable network of courier services and postal processing systems are the ideal laboratory to provide this service".
Submission forms are available free of charge from Invicta Animal Health 01403 791313. ChroMyco Duo dermatophyte test kits are available from wholesalers and priced at £25.00 for 5 kits.
The University of Surrey has announced that it is to launch a new school of veterinary medicine in 2014.
According to the University, the new school will embrace the 'One Health - One Medicine' philosophy and will include the development of a unique research-led veterinary medicine degree programme with an emphasis on research, veterinary pathology and livestock medicine.
The new school will be based at the University of Surrey's Manor Park site in Guildford, in order to encourage collaboration of students and staff from different disciplines, with those studying towards a veterinary medicine qualification being exposed to engineering and physics as well as receiving training in core business skills.
The new School of Veterinary Medicine at Surrey will be delivered through collaborations with key partners including: the Animal Health and Veterinary Laboratories Agency (AHVLA), the BBSRC Pirbright Institute, the Veterinary Medicines Directorate (VMD), Fitzpatrick Referrals, Liphook Equine Hospital and Westpoint Farm Vets. The University says it is looking to extend its relationships with regional veterinary practices over the coming year.
Students will also be exposed to global issues concerning animal health through the University Global Partnership Network (UGPN), a trilateral agreement between Surrey, North Carolina State and São Paulo Universities through teaching collaborations, summer scholarships and research exchanges.
Professor Lisa Roberts, Dean of the Faculty of Health and Medical Sciences at the University of Surrey, said: "As a research-intensive University we have the expertise, reputation, technical and business skills which our students can benefit from, allowing us to train the veterinary leaders of the future. Combining state-of-the-art facilities, our unique partnerships and a campus location, the new School will provide a stimulating environment not only for undergraduates, but for the professional development training of qualified veterinary surgeons."
Professor John Fazakerley, Director of The Pirbright Institute, said: "This is good news for the UK veterinary research community. The Pirbright Institute currently works in close collaboration with the University of Surrey on research that benefits animal health and welfare; we very much look forward to building on this established and growing association as the new school of veterinary medicine is launched. There is an important place for trained veterinarians in scientific research and we are delighted that the University has decided to emphasise these areas in particular."
Professor Andy Durham of the Liphook Equine Hospital said: "The new School of Veterinary Medicine development programme at the University of Surrey is ideally timed to provide an alternative to the traditional veterinary education and to respond to the demands of a changing profession with fresh plans, ideas and enthusiasm. Enticing newly developed facilities make Guildford an excellent student town and with several collaborative specialist partners within the locality the new School of Veterinary Medicine is perfectly placed geographically to provide a veterinary education fitting for the 21st century."
The University is also in consultation with the Royal College of Veterinary Surgeons. Freda Andrews, Head of Education at the RCVS, said: "We were pleased to meet Professor Sir Christopher Snowden, President and Vice-Chancellor and his colleagues from the University of Surrey recently, and interested to hear their proposals to develop a new School of Veterinary Medicine. We will be working with them over the coming months to develop a timetable for considering the new programme against our accreditation standards. The monitoring process will take a number of years."
The University says it has already laid the foundations for the new School through its expansion of teaching and research activities in its Faculty of Health and Medical Sciences, including the launch of the BSc programme in Veterinary Biosciences in 2009 and in October of this year a new MSc in Veterinary Microbiology. A new MSc in Veterinary Pathology is also currently under development.
The University says that over the next 12 months it will be recruiting new academic staff, attracting the first cohort of students and beginning building works in preparation for the first cohort of students in 2014.
Vétoquinol, manufacturer of Epiphen (phenobarbital), for the control of epilepsy in dogs, has announced the launch of a new starter pack for clients that are embarking on treatment.
The starter packs contain a variety of support materials designed to help owners better understand the condition and its treatment. They sit alongside other support given by the company, which includes an 'Ask the Expert' helpline through which Epiphen veterinary customers can speak to a neurology specialist at The Animal Health Trust in Newmarket, where Vetoquinol sponsors a neurology clinician.
Abbie King, Product Manager for Epiphen, said: ''Our 'Ask the Expert' helpline is a successful service that has been running for several years. 30% of the calls to Vetoquinol's technical team relate to this challenging condition meaning there are few queries our technical team have not tackled before. If extra help is necessary we have an excellent working relationship with The Animal Health Trust and regularly refer cases to them for further advice. We are very proud of this service and are delighted to be able to continue to provide this helpline for our Epiphen clients.''
To use the 'Ask the Expert' service, or order the support materials, ring 0800 1698197. Alternatively visit: www.vetoquinol.co.uk or www.epiphenonline.co.uk.
VetSurgeon Profiles offer the same sort of features you find on external social networks like Linkedin and Facebook, but in a professional format designed specially for the veterinary profession.
They've been developed to help veterinary job seekers, locums, referral practitioners and forum contributors in particular:
VETERINARY JOB SEEKERSVetSurgeon Profiles have been designed to help you create what is essentially a polished CV. You can include details of where you qualified, which postgraduate qualifications you hold, your clinical interests, and your work experience.
Importantly, VetSurgeon Profiles have also been integrated within VetSurgeon Jobs. So now, when you respond to a job advert by clicking the email address given in the contact details, your email program will open a new message containing a link to your VetSurgeon Profile, ready to send to the advertiser (you must be logged in for this to work).
VETERINARY LOCUMSVetSurgeon Profiles are also integrated within the VetSurgeon Locum Map, making them a great way to advertise your skillset to hiring practices.
REFERRAL PRACTITIONERSVetSurgeon Profiles allow you to display just about every letter of the alphabet after your name, but in a way that is designed to be 'matter of fact' rather than 'showy'. Combined with the ability to display your work experience and interests, they’re a great way to show why you’re the person to refer that tricky case to. And you can now display your telephone number too.
VETSURGEON FORUM CONTRIBUTORSHaving a good profile displayed really helps build a sense of connection with other members. Perhaps more importantly, though, they help give your words context. When reading a post, it's so helpful to know when the author qualified, where, and what makes them tick.
Ultimately, though, VetSurgeon Profiles are for anyone and everyone who wants to be better connected with others in the profession, and the plan is to develop more and more features which help do precisely that.
To create your VetSurgeon Profile, visit the site, click ‘My Account’, then ‘View My Profile’ and add your details to the page. Here's one I prepared earlier.
VetSurgeon Profiles are only visible to logged in members of VetSurgeon.org.
Norbrook Laboratories has launched Cefimam DC intramammary ointment, a new dry cow preparation containing the 4th generation cephalosporin, cefquinome.
The company has also released a Polish language version of its Best Practice Guide for On-Farm Mastitis Control, in response to demand from producers with non-English speaking farm-hands.
Norbrook vet Chris Geddes said: "I believe this is the first time that such a guide has been produced to cater for farm-hands of a different nationality working within the UK. Good mastitis management starts with good education; giving everyone on the farm the same opportunity for learning the best techniques for prevention means that we help minimise incidences of mastitis, which costs the dairy industry millions of pounds in lost revenue every year.
"This prevention includes a thorough and consistent approach to dry cow management. The early drying off period is often a risky time, when pre-existing subclinical infections can bed-in. The cow is also at increased risk of gaining new infections due to lack of udder hygiene procedures that would normally occur at milking, and weakened immunity as she approaches calving. Our new cefquinome preparation is a valuable addition to have in the treatment armoury for dry cow management. It has broad-spectrum activity and high cellular penetration to help tackle hard-to-manage cases with the aim of returning to maximum productivity by the start of the milking season."
Cefimam DC will be available at all veterinary wholesalers in packs of 24x and 120x 8g intramammary tubes. Vets can obtain both English and Polish versions of the Best Practice Guide for On-Farm Mastitis Control from Territory Managers.
For further information or copies of the Best Practice Guide for On-Farm Mastitis Control in English or Polish, contact your Territory Manager or call Norbrook GB head office on 01536 741 147.
'Period prevalence and mortality rates associated with hypocholesterolaemia in dogs and cats: 1,375 cases1' determined the period prevalence of hypocholesterolaemia and the associated mortality rates in dogs and cats at the Veterinary Medical Teaching Hospital, University of California, Davis.
The medical records of cats and dogs presenting to the hospital from 1st September 2011 to 30th August 2016 were retrospectively reviewed to identify all animals that had at least 1 cholesterol measurement; a total of 16,977 dogs and 3,788 cats were identified. Patient signalment and clinical information were collated from the medical records, including the primary disease processes in patients with moderate to severe hypocholesterolaemia. The period prevalence and mortality rate of hypocholesterolaemia were calculated.
The period prevalence of hypocholesterolaemia was 7.0% in dogs and 4.7% in cats. The mortality rate of hypocholesteraemic dogs and cats was 12% in both species, which was significantly higher than that of animals with normal serum cholesterol.
Steven Epstein, corresponding author for the paper, said: 'The odds of death in dogs and cats with hypocholesterolaemia were 3.2 and 2.5 times higher than in those with normocholesterolaemia respectively. Furthermore, there was a significant linear trend towards higher mortality in association with more severe hypocholesterolaemia in both species.
'Disease of the hepatic, gastrointestinal and lymphoreticular systems were most commonly associated with hypocholesterolaemia, and infectious and neoplastic disease were the most commonly associated pathophysiological processes in both species. In dogs with neoplasia, lymphoma was over-represented.'
Nicola Di Girolamo, Editor of JSAP said: 'These findings suggest that low cholesterol levels are associated with mortality in canine and feline patients. It is not clear whether hypocholesterolaemia is simply a marker for disease severity, or if it has active physiological effects contributing to poor outcomes. At this stage, it seems indicated to enhance intensity of diagnostic effort and therapy for affected animals.'
The full article can be found in the November issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13204
Reference